PUMD OTC
ProUroCare Medical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -50.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.00505
Volume26,169
Avg Volume380
Beta0.31
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBenjamin Banks
Employees2
SectorHealthcare
IndustryMedical - Devices
IPO Date2022-11-29
Websiteprourocare.com
6440 Flying Cloud Drive
Eden Prairie, MN 55416
US
Eden Prairie, MN 55416
US
+1 952 746 1555
About ProUroCare Medical Inc.
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Smith Scott E | J-Other | 0 | $1.30 | 2013-09-20 |
| KAYSEN DAVID B | 0 | — | 2013-09-09 | |
| Barrett David M | A-Award | 2,605 | $0.64 | 2012-12-28 |
| Smith Scott E | M-Exempt | 3,272 | $1.10 | 2012-12-28 |
| Smith Scott E | M-Exempt | 3,272 | $1.10 | 2012-12-28 |